ConductScience.org, home

Paper6413638

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.

Grimm EA and 6 others. J Exp Med, 1983. Cited by 468 papers, by iCite.

Cite this record

ConductScience Library. Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. Papers, record 6413638. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6413638

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.
PubMed
Journal
J Exp Med
PubMed
Year
1983
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
468
iCite
Relative citation ratio, by iCite
10.5
iCite
Revised in PubMed
2019-05-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grimm EAE A
2Robb RJR J
3Roth JAJ A
4Neckers LML M
5Lachman LBL B
6Wilson DJD J
7Rosenberg SAS A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-2Major topic
Killer Cells, NaturalMajor topic
Lymphocyte ActivationMajor topic
Antibodies, Monoclonal
Binding, Competitive
Humans
Lymphocytes
Phenotype
Receptors, Immunologic
Receptors, Interleukin-2
Stem Cells

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11087116Identification of T cell lymphoma tumor antigens on human T cell lines.Am J Hematol1976https://conductscience.org/library/papers/1087116PubMed
26966652In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.J Immunol1980https://conductscience.org/library/papers/6966652PubMed
36778951Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.J Exp Med1980https://conductscience.org/library/papers/6778951PubMed
46970774A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.J Immunol1981https://conductscience.org/library/papers/6970774PubMed
56453159In vitro growth of cytotoxic human lymphocytes. III. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity.J Immunol1981https://conductscience.org/library/papers/6453159PubMed
66785531Purification of human interleukin 1.J Supramol Struct1980https://conductscience.org/library/papers/6785531PubMed
76975300Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.J Immunol1981https://conductscience.org/library/papers/6975300PubMed
86975347T cell growth factor receptors. Quantitation, specificity, and biological relevance.J Exp Med1981https://conductscience.org/library/papers/6975347PubMed
96975652Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.Cancer Res1981https://conductscience.org/library/papers/6975652PubMed
106976987The purification and properties of human T cell growth factor.J Immunol1982https://conductscience.org/library/papers/6976987PubMed
116176669Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.J Exp Med1982https://conductscience.org/library/papers/6176669PubMed
127047366Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor.Immunobiology1982https://conductscience.org/library/papers/7047366PubMed
136815536A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.Nature1982https://conductscience.org/library/papers/6815536PubMed

Download CSV of references

Cited by78

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 468 citations.

PMIDTitleJournalYearIn PapersSource
41135520Engineered natural killer cells for cancer therapy.Cancer Cell2025https://conductscience.org/library/papers/41135520PubMed
37218360Inhibiting N-glycan processing increases the antibody binding affinity and effector function of human natural killer cells.Immunology2023https://conductscience.org/library/papers/37218360PubMed
36588388Advanced T and Natural Killer Cell Therapy for Glioblastoma.J Korean Neurosurg Soc2023https://conductscience.org/library/papers/36588388PubMed
35720306Next Generation Natural Killer Cells for Cancer Immunotherapy.Front Immunol2022https://conductscience.org/library/papers/35720306PubMed
34169631There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment.Vet Comp Oncol2021https://conductscience.org/library/papers/34169631PubMed
31907401NK cells for cancer immunotherapy.Nat Rev Drug Discov2020https://conductscience.org/library/papers/31907401PubMed
31798595CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.Front Immunol2019https://conductscience.org/library/papers/31798595PubMed
28545888Delivering safer immunotherapies for cancer.Adv Drug Deliv Rev2017https://conductscience.org/library/papers/28545888PubMed
27372731Chimeric antigen receptors: driving immunology towards synthetic biology.Curr Opin Immunol2016https://conductscience.org/library/papers/27372731PubMed
24376448Regulation of mouse NK cell development and function by cytokines.Front Immunol2013https://conductscience.org/library/papers/24376448PubMed
22027907IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.Melanoma Res2012https://conductscience.org/library/papers/22027907PubMed
21716670Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy.J Biomed Biotechnol2011https://conductscience.org/library/papers/21716670PubMed
21487512Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.Self Nonself2010https://conductscience.org/library/papers/21487512PubMed
21432415Cigarette smoking is associated with the reduction of lymphokine-activated killer cell and natural killer cell activities.Environ Health Prev Med1996https://conductscience.org/library/papers/21432415PubMed
20734041Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.Cancer Immunol Immunother2010https://conductscience.org/library/papers/20734041PubMed
20237297Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice.J Immunol2010https://conductscience.org/library/papers/20237297PubMed
15693143Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasms.Cancer Immunol Immunother2005https://conductscience.org/library/papers/15693143PubMed
10815620Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.Mediators Inflamm1999https://conductscience.org/library/papers/10815620PubMed
9659223Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.Immunology1998https://conductscience.org/library/papers/9659223PubMed
9617349Enhancement of anti-tumor activity of natural killer cells by BALL-1, a B cell lymphoma line.Jpn J Cancer Res1998https://conductscience.org/library/papers/9617349PubMed

See all 78 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6413638

GET https://conductscience.org/api/papers/v1/6413638/cited_by?page=2